Articles & Issues

Full Text and Abstracts

Cover Image

Abstracts of Swisstransfusion 2010: Joint Congress of World Apheresis Organisation (WAA), Interdisciplinary European Society for Haemapheresis and Haemotherapy (ESFH), Blood Transfusion Service of the Swiss Red Cross (BTS/SRC), Swiss Association of Transfusion Medicine (SATM)

02 September 2010 - 04 September 2010

Search Within This Issue

56 Articles:

  • 1
Abstracts of Swisstransfusion 2010, Joint Congress of WAA, ESFH, BTS/SRC, SATM
Invited abstracts
Article Title Author(s) Pages
58 Immunoadsorption in idiopathic dilated cardiomyopathy

D. Bulut S1
12 Efficacy of plasma filtration with dialysis (plasma dia-filtration) for the patients with septic multiple organ failure including hyperbilirubinemia

Y. Eguchi S1
7 Apheresis in neuromyelitis optica

K. Fujihara S2
4 Cytapheresis therapy for Crohn's disease in Japan

J. Kato S2-S3
51 Extracorporeal immune modulation of sensitized solid organ transplant recipients

S. Rummler, D. Barz S3
59 Immunoadsorption in autoimmune bullous disorders

E. Schmidt S3
8 Extracorporeal blood endotoxin removal therapy for the treatment of severe sepsis and septic shock

T. Tani, H. Shorgi S4
3 Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C

T. Yamashita, A. Sakai, K. Fujiwara, S. Kaneko S4
Orals (international)
Article Title Author(s) Pages
6 Development of optimum therapeutic strategy for refractory ulcerative colitis with acute flare: current status of the CELLSORBA leukocytapheresis in Japan

K. Fukunaga S4-S5
52 PBPC - is there any mobilization of CD 34+ cells in the course of PBPC collections?

Z. Gasova, M. Bohmova, Z. Bhuiyan-Ludvikova, E. Novotova S5
55 Current status of apheresis in Korea

K. Han, E. Song, H. Kim, S. Kwon, D. Kim, J. Lee, Q. Park et al. S5-S6
26 Collection of peripheral blood stem cells in allogeneic donors via femoral venous lines - safe, successful and well-tolerated

K. Höolig, M. Blechschmidt, K. Poppe-Thiede, M. Kramer, K. Zimmer, F. Kroschinsky, M. Bornhäuser, G. Ehninger et al. S6
13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan

M. Iwamoto, K. Shigetoh, H. Maruyama, T. Kondo S6-S7
20 Donor apheresis activities around the world: results of an international survey

R. Moog S7
5 Triple platelet dose collection is a safe and feasible apheresis procedure

R. Moog S7
34 Mononuclear cell collection in patients treated with extracorporeal photochemotherapy by using the off-line method: a comparison between COBE Spectra AutoPbsc version 6.1 and Amicus cell separators

P. Perseghin, A. Incontri S7-S8
40 Difference between ferritin decline using therapeutic erythrocytapheresis versus phlebotomy in the treatment of hemochromatosis patients

E. Reuser, J. Heeremans, E. Rombout-Sestrienkova S8
41 Therapeutic erythrocytapheresis versus phlebotomy in the treatment of hemochromatosis patients. Results of the cost analysis from a randomised, feasibility and proof of principle trial

E. Rombout-Sestrienkova, P. van Noord, E. Reuser, J. Heeremans, G. Koek, B. Essers et al. S9
36 Report of World Apheresis Association registry data until June 2010

B. Stegmayr, J. Ptak, T. Nilsson, M. Blaha, G. Berlin, A. Griskevicius, J. Audzijoniene, W. Ramlow, P. Centoni, E. Newman, J. Tomaz, V. Witt, L. Stojkovski, S. Eloot, K. Lalic, G. Liumbruno, P. Molfettini, M. Efvergren, R. Norda, F. Knutson, C. Axelsson, M. Mörtzell, E. Lassen, H. Prophet et al. S9-S10
45 Low cyclophosphamide dose and plasma exchange a less toxic induction treatment of ANCA associated vasculitis

W. Szpirt, E. Krarup, M. Egfjord S10
22 The predictive markers of response for cytapheresis in active ulcerative colitis

Y. Yokoyama, K. Fukunaga, K. Kamikozuru, K. Nagase, K. Katou, R. Kikuyama, N. Takeda, T. Matsumoto et al. S11
33 Apheresis quality and donor safety and tolerance in triple platelet apheresis. Final results from the DGTI hemapheresis multicentre trial

J. Zingsem, R. Moog, E.G. Fischer, H.G. Heuft S11-S12
Orals (national)
Article Title Author(s) Pages
50 Ageing and storage of erythrocyte concentrates

J. Delobel, O. Rubin, D. Crettaz, JD. Tissot, N. Lion et al. S12
28 Serology helps moleculardiagnostics to solve a rare case of homozygous FY*X/FY*X - consequences for transfusion recommendations

C. Engström, B. Grossrieder, C. Gassner, B.M. Frey S12-S13
17 An evaluation of preventive measures to reduce the risk of TRALI after transfusion of single donor apheresis platelets in Switzerland

S. Fontana, J. Thierbach, M. Muriset, J. Sigle, P. Gowland, C. Niederhauser, K. Sunic, L. Infanti, A. Buser et al. S13
23 DARA, a new DAR variant - serologic and molecular differences between DARA, weak D type 4.2.2, DV type 7, DARE, and DAR

S. Lejon, P. Gowland, S. Fontana, C. Niederhauser, H. Hustinx et al. S13-S14
49 Using Luminex-HLA-antibody- and Luminex-HLA-crossmatch-technology as a preliminary decision support for kidney-transplantation

K. Sunic, J. Thierbach S14
47 Prospective paired study on irradiation of fresh red blood cells: evidence for a significant storage lesion within 24 hours

M. Vogt, R. Brüllhardt, T. Schulzki, B. Mansouri Taleghani S14-S15
Posters (international)
Article Title Author(s) Pages
24 Effect of granulocyte-colony stimulating factor on hemostatic function in normal healthy allogenic donors undergoing large volume leukapheresis

P. Agarwal, S. Nityanand, P. Pandey, D. Khetan, R. Chaudhry et al. S15
18 Clinical importance of statin monitoring after extracorporeal LDL-cholesterol elimination

M. Blaha, L. Novakova, H. Vlckova, D. Solichova, P. Solich, M. Lanska, S. Filip, J. Maly et al. S15-S16
19 Extracorporeal immunoglobulin elimination in the long-term treatment of severe myasthenia gravis

M. Blaha, J. Pitha, V. Blaha, M. Lanska, S. Filip, H. Langrova et al. S16-S17
44 Effect of plateletpheresis on post donation platelet count and its correlation with serum thrombopoeitin levels

R. Chaudhary S17
11 Transplantation of heterogenous population bone marrow cells and in vivo homing

S. Filip S17
57 Acquired factor XIII inhibitor: multimodal therapeutic approach with finally including immunoadsorption

B. Mansouri Taleghani, F. Boehlen, C. Chizzolini, T. Kössler, T. Matthes, E. Ortner, M. Blondon, Y. Tirefort, G. Reber, P. de Moerloose et al. S17-S18
9 Effect of temperature on separation characteristics in a plasma fractionator

M. Mineshima, Y. Konno, K. Eguchi, I. Kaneko S18
38 Analyses of data of patients with thrombotic microangiopathy in the WAA registry

M. Mörtzell, J. Ptak, C.G. Axelsson, G. Berlin, A. Griskevicius, T. Nilsson, K. Mokvist, M. Blaha, J. Tomaz, M. Efvergren, E. Newman, S. Eloot, B. Stegmayr et al. S18-S19
16 A modified filter-type device (Cellsorba EX Global type) for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis: a pilot study. LL-37 is generated during apheresis session

V. Muratov, A. Mandic-Havelka, K. Elvin, Å. Óst, K. Furaya, Y. Shizume, R. Löfberg, J. Lundahl et al. S19
31 Cytokine profiles during the granulocyte/monocyte apheresis for Crohn's disease

K. Nagase, K. Fukunaga, Y. Yokoyama, K. Kamikozuru, R. Kikuyama, K. Kato, M. Yamada, H. Miwa, T. Matsumoto et al. S19-S20
10 Five patients in one family (treatment of hereditary hemochromatosis), case report

J. Ptak, K. Sedlackova S20
39 Glaucoma a new indication for immunoadsorption

J. Rech, G. Wallukat, G. Schett, M. Herrmann, R. Kunze, A. Juenemann et al. S20
53 Profile of platelet donor apheresis in the department of immunohemotherapy - IPOPFG-EPE

B. Robelo, R. Carneiro, I. Ribeiro, A.P. Espirito Santo, L. Mendes, M.J. Mendes, M. França, P. Torres, M. Rosales, M.J. Milheiro, L. Santos, A. Carvalhais et al. S20-S21
54 Satisfaction of unrelated donor after haematopoietic stem cell collection

M. Rosales, S. Ferreira, P. Torres, S. Roncon, I. Barbosa, F. Amado, S. Lopes, F. Bordalo, A. Bernardo, A. Carvalhais et al. S21-S22
21 Quality control of apheresis platelets in two years time interval

M. Sindjic Milicevic, N. Vavic, V. Srejic, S. Milutinovic, I. Jeremic Jojic, Z. Spuran, M. Dukic Novakovic et al. S22
42 Experience of the cascade filtration use

A.A. Sokolov, A.R. Osmak, A.N. Belskih S22-S23
29 Therapeutic plasma exchange in neurological patients treated from January to December 2009

V. Srejic S23
43 Apheresis medical tourism in India, emergence of a new trend - combined/adjunctive therapeutic membrane filtration apheresis in SLE with Sjögren's syndrome overlap. An Indian experience, is it promising?

R. Srivastava, A. Lalchandani S23
56 Holistic combo approach of autoimmune disorders management - a novel Indian way

R. Srivastava, S. Kaur S23-S24
37 Can immune adsorption help to develop tolerance of the immune system to overcome severe antibody mediated immunological response? Report of a case with severe Wegener's granulomatosis

B. Stegmayr S24
Posters (national)
Article Title Author(s) Pages
35 Therapeutic leukocyte depletion in CLL at Hb-level of 37 g/l

M. Braisch, F. Hitz, J. Thierbach S24
48 Thrombocytopenia, fibrinogen and F. XIII deficiency in the perioperative setting

E.J. Forrest, W.C. Korte S24-S25
27 First case of HIV window donation in Switzerland after 8 years of universal HIV NAT screening

J. Gottschalk, Y. Achermann, C. Niederhauser, C. Tinguely, A. Glauser, P. Lodemann, B.M. Frey et al. S25
15 Prospective comparison of efficiacy of therapeutic apheresis versus conventional phlebotomy - preliminary data from hemochromatosis patients

P. Lodemann, G. Schorer, J. Ries, B.M. Frey S25
25 Fatal outcome of a hepatitis B virus transfusion-transmitted infection

C. Niederhauser, T. Weingand, A. Maier, W.A. Wuillemin, C. Tinguely, P. Gowland, M. Stolz et al. S26
32 First Swiss case of severe transfusion reaction due to immunoglobulin A deficiency

L. Pizzi Bosman, J. Rosochova, J. Scemama Clergue S26-S27
Author index

S29-S30
List of Sponsors

S31

56 Articles:

  • 1